CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Imatinib Mesylate

甲磺酸伊马替尼 杂质对照品Imatinib Mesylate Impurities

EP55 个杂质条目55 impurity entries

本页汇总 甲磺酸伊马替尼 的 55 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 55 impurity reference standards of Imatinib Mesylate with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 甲磺酸伊马替尼(Imatinib Mesylate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesCharacterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile
    Biomedical chromatography : BMC · 2018 · Wolff FC et al.  ·  PMID 29488235  ·  DOI
  2. 杂质研究Impurity studiesStability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms
    Journal of pharmaceutical and biomedical analysis · 2012 · Nageswari A et al.  ·  PMID 22502910  ·  DOI
  3. 杂质研究Impurity studiesDetermination of sulfonate ester genotoxic impurities in imatinib mesylate by gas chromatography with mass spectrometry
    Journal of separation science · 2016 · Zhang C et al.  ·  PMID 27461842  ·  DOI
  4. 分析方法Analytical MethodsMethod development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2011 · Tan KL et al.  ·  PMID 22000961  ·  DOI
  5. 分析方法Analytical MethodsQuantification of imatinib in human serum: validation of a high-performance liquid chromatography-mass spectrometry method for therapeutic drug monitoring and pharmacokinetic assays
    Drug design, development and therapy · 2013 · Rezende VM et al.  ·  PMID 23946646  ·  DOI

甲磺酸伊马替尼 —— 原料药与杂质对照品Imatinib Mesylate — drug substance & impurities

共 55 个条目(含原料药本体)55 items incl. the drug substance
Imatinib Mesylate structure
EP原料药 APIAPI
甲磺酸伊马替尼Imatinib Mesylate
Imatinib Mesylate
CAS No.220127-57-1
Chemical FormulaC29H31N7O·CH4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 46 (Imatinib Mesylate EP Impurity A) structure
EPA
甲磺酸伊马替尼杂质46 (甲磺酸伊马替尼EP杂质A)Imatinib Mesylate Impurity 46 (Imatinib Mesylate EP Impurity A)
Imatinib Mesylate Impurity 46 (Imatinib Mesylate EP Impurity A)
CAS No.123367-26-0
Chemical FormulaC10H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 10 (Imatinib Mesylate EP Impurity B) structure
EPB
甲磺酸伊马替尼杂质10 (甲磺酸伊马替尼EP杂质B)Imatinib Mesylate Impurity 10 (Imatinib Mesylate EP Impurity B)
Imatinib Mesylate Impurity 10 (Imatinib Mesylate EP Impurity B)
CAS No.581076-65-5
Chemical FormulaC21H28N6O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib EP Impurity B DiHCl structure
EPB
伊马替尼EP杂质B二盐酸Imatinib EP Impurity B DiHCl
Imatinib EP Impurity B DiHCl
CAS No.581076-67-7
Chemical FormulaC21H29ClN6O
Purity>95%现货In stock
10mg25mg50mg100mg
Imatinib Mesylate Impurity 39 (N1-Nitroso Imatinib Mesylate EP Impurity C) structure
EPC
甲磺酸伊马替尼杂质39 (N1-亚硝基甲磺酸伊马替尼EP杂质C)Imatinib Mesylate Impurity 39 (N1-Nitroso Imatinib Mesylate EP Impurity C)
Imatinib Mesylate Impurity 39 (N1-Nitroso Imatinib Mesylate EP Impurity C)
CAS No.2816369-80-7
Chemical FormulaC28H28N8O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 6 (Imatinib Mesylate EP Impurity C) structure
EPC
甲磺酸伊马替尼杂质6 (甲磺酸伊马替尼EP杂质C)Imatinib Mesylate Impurity 6 (Imatinib Mesylate EP Impurity C)
Imatinib Mesylate Impurity 6 (Imatinib Mesylate EP Impurity C)
CAS No.404844-02-6
Chemical FormulaC28H29N7O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 17 Monomer (Imatinib Mesylate EP Impurity D) structure
EPD
甲磺酸伊马替尼杂质17 单体 (甲磺酸伊马替尼EP杂质D)Imatinib Mesylate Impurity 17 Monomer (Imatinib Mesylate EP Impurity D)
Imatinib Mesylate Impurity 17 Monomer (Imatinib Mesylate EP Impurity D)
CAS No.1821122-73-9
Chemical FormulaC53H51N12O2+
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 20 (Imatinib Mesylate EP Impurity F) structure
EPF
甲磺酸伊马替尼杂质20 (甲磺酸伊马替尼EP杂质F)Imatinib Mesylate Impurity 20 (Imatinib Mesylate EP Impurity F)
Imatinib Mesylate Impurity 20 (Imatinib Mesylate EP Impurity F)
CAS No.152460-10-1
Chemical FormulaC16H15N5
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 35 (Imatinib Mesylate EP Impurity H) structure
EPH
甲磺酸伊马替尼杂质35 (甲磺酸伊马替尼EP杂质H)Imatinib Mesylate Impurity 35 (Imatinib Mesylate EP Impurity H)
Imatinib Mesylate Impurity 35 (Imatinib Mesylate EP Impurity H)
CAS No.350-03-8
Chemical FormulaC7H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 4 (Imatinib Mesylate EP Impurity J) structure
EPJ
甲磺酸伊马替尼杂质4 (甲磺酸伊马替尼EP杂质J)Imatinib Mesylate Impurity 4 (Imatinib Mesylate EP Impurity J)
Imatinib Mesylate Impurity 4 (Imatinib Mesylate EP Impurity J)
CAS No.571186-91-9
Chemical FormulaC29H31N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib structure
—
伊马替尼Imatinib
Imatinib
CAS No.152459-95-5
Chemical FormulaC29H31N7O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 1 structure
1
甲磺酸伊马替尼杂质1Imatinib Mesylate Impurity 1
Imatinib Mesylate Impurity 1
CAS No.571186-92-0
Chemical FormulaC29H31N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 2 structure
2
甲磺酸伊马替尼杂质2Imatinib Mesylate Impurity 2
Imatinib Mesylate Impurity 2
CAS No.571186-93-1
Chemical FormulaC29H31N7O3
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 3 structure
3
甲磺酸伊马替尼杂质3Imatinib Mesylate Impurity 3
Imatinib Mesylate Impurity 3
CAS No.938082-57-6
Chemical FormulaC29H31N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 7 structure
7
甲磺酸伊马替尼杂质7Imatinib Mesylate Impurity 7
Imatinib Mesylate Impurity 7
CAS No.1246819-59-9
Chemical FormulaC29H31N7O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Impurity 10 structure
10
甲磺酸伊马替尼杂质8Imatinib Impurity 10
Imatinib Impurity 10
CAS No.1026753-54-7
Chemical FormulaC29H31N7O
Purity>95%现货In stock
10mg25mg50mg100mg
Imatinib Mesylate Impurity 13 Monomer structure
13
甲磺酸伊马替尼杂质13 单体Imatinib Mesylate Impurity 13 Monomer
Imatinib Mesylate Impurity 13 Monomer
CAS No.942514-62-7
Chemical FormulaC30H33N7O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 14 structure
14
甲磺酸伊马替尼杂质14Imatinib Mesylate Impurity 14
Imatinib Mesylate Impurity 14
CAS No.152460-09-8
Chemical FormulaC16H13N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 15 structure
15
甲磺酸伊马替尼杂质15Imatinib Mesylate Impurity 15
Imatinib Mesylate Impurity 15
CAS No.1365802-18-1
Chemical FormulaC52H48N12O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 16 structure
16
甲磺酸伊马替尼杂质16Imatinib Mesylate Impurity 16
Imatinib Mesylate Impurity 16
CAS No.1076199-23-9
Chemical FormulaC33H37N7O3
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 19 structure
19
甲磺酸伊马替尼杂质19Imatinib Mesylate Impurity 19
Imatinib Mesylate Impurity 19
CAS No.55314-16-4
Chemical FormulaC10H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 21 structure
21
甲磺酸伊马替尼杂质21Imatinib Mesylate Impurity 21
Imatinib Mesylate Impurity 21
CAS No.404844-11-7
Chemical FormulaC24H20ClN5O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 22 structure
22
甲磺酸伊马替尼杂质22Imatinib Mesylate Impurity 22
Imatinib Mesylate Impurity 22
CAS No.2410195-20-7
Chemical FormulaC17H15N5O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 24 structure
24
甲磺酸伊马替尼杂质24Imatinib Mesylate Impurity 24
Imatinib Mesylate Impurity 24
CAS No.581076-64-4
Chemical FormulaC8H12N4
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 27 structure
27
甲磺酸伊马替尼杂质27Imatinib Mesylate Impurity 27
Imatinib Mesylate Impurity 27
CAS No.1356565-46-2
Chemical FormulaC42H47N9O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 31 structure
31
甲磺酸伊马替尼杂质31Imatinib Mesylate Impurity 31
Imatinib Mesylate Impurity 31
CAS No.1356565-47-3
Chemical FormulaC17H17N7
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 36 structure
36
甲磺酸伊马替尼杂质36Imatinib Mesylate Impurity 36
Imatinib Mesylate Impurity 36
CAS No.106261-48-7
Chemical FormulaC13H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 36 Dihydrochloride structure
36
甲磺酸伊马替尼杂质36 双盐酸盐Imatinib Mesylate Impurity 36 Dihydrochloride
Imatinib Mesylate Impurity 36 Dihydrochloride
CAS No.106261-49-8
Chemical FormulaC13H18N2O2·2HCl
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 37 structure
37
甲磺酸伊马替尼杂质37Imatinib Mesylate Impurity 37
Imatinib Mesylate Impurity 37
CAS No.152459-96-6
Chemical FormulaC24H21N5O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 40 structure
40
甲磺酸伊马替尼杂质40Imatinib Mesylate Impurity 40
Imatinib Mesylate Impurity 40
CAS No.581076-66-6
Chemical FormulaC24H19Cl2N5O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 41 structure
41
甲磺酸伊马替尼杂质41Imatinib Mesylate Impurity 41
Imatinib Mesylate Impurity 41
CAS No.870459-88-4
Chemical FormulaC8H10N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 42 structure
42
甲磺酸伊马替尼杂质42Imatinib Mesylate Impurity 42
Imatinib Mesylate Impurity 42
CAS No.796738-72-2
Chemical FormulaC8H10N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 44 structure
44
甲磺酸伊马替尼杂质44Imatinib Mesylate Impurity 44
Imatinib Mesylate Impurity 44
CAS No.125888-48-4
Chemical FormulaC8H10N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 45 structure
45
甲磺酸伊马替尼杂质45Imatinib Mesylate Impurity 45
Imatinib Mesylate Impurity 45
CAS No.220213-15-0
Chemical FormulaC12H16N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 47 structure
47
甲磺酸伊马替尼杂质47Imatinib Mesylate Impurity 47
Imatinib Mesylate Impurity 47
CAS No.75415-01-9
Chemical FormulaC10H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 48 structure
48
甲磺酸伊马替尼杂质48Imatinib Mesylate Impurity 48
Imatinib Mesylate Impurity 48
CAS No.205517-34-6
Chemical FormulaC23H28N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 49 structure
49
甲磺酸伊马替尼杂质49Imatinib Mesylate Impurity 49
Imatinib Mesylate Impurity 49
CAS No.1122-62-9
Chemical FormulaC7H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 50 structure
50
甲磺酸伊马替尼杂质50Imatinib Mesylate Impurity 50
Imatinib Mesylate Impurity 50
CAS No.112696-91-0
Chemical FormulaC16H15N5
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 52 structure
52
甲磺酸伊马替尼杂质52Imatinib Mesylate Impurity 52
Imatinib Mesylate Impurity 52
CAS No.1219828-35-9
Chemical FormulaC24H19N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 53 structure
53
甲磺酸伊马替尼杂质53Imatinib Mesylate Impurity 53
Imatinib Mesylate Impurity 53
CAS No.581076-63-3
Chemical FormulaC20H26N4O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 54 structure
54
甲磺酸伊马替尼杂质54Imatinib Mesylate Impurity 54
Imatinib Mesylate Impurity 54
CAS No.67013-55-2
Chemical FormulaC8H5Br2N
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 55 structure
55
甲磺酸伊马替尼杂质55Imatinib Mesylate Impurity 55
Imatinib Mesylate Impurity 55
CAS No.1407124-83-7
Chemical FormulaC16H13N5O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 56 structure
56
甲磺酸伊马替尼杂质56Imatinib Mesylate Impurity 56
Imatinib Mesylate Impurity 56
CAS No.1384131-91-2
Chemical FormulaC7H11NO
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 57 structure
57
甲磺酸伊马替尼杂质57Imatinib Mesylate Impurity 57
Imatinib Mesylate Impurity 57
CAS No.1256080-10-0
Chemical FormulaC32H31N9O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 61 structure
61
甲磺酸伊马替尼杂质61Imatinib Mesylate Impurity 61
Imatinib Mesylate Impurity 61
CAS No.1122-54-9
Chemical FormulaC7H7NO
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 62 structure
62
甲磺酸伊马替尼杂质62Imatinib Mesylate Impurity 62
Imatinib Mesylate Impurity 62
CAS No.125743-63-7
Chemical FormulaC13H17N3
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 64 structure
64
甲磺酸伊马替尼杂质64Imatinib Mesylate Impurity 64
Imatinib Mesylate Impurity 64
CAS No.111043-09-5
Chemical FormulaC7H6BrNO
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 65 structure
65
甲磺酸伊马替尼杂质65Imatinib Mesylate Impurity 65
Imatinib Mesylate Impurity 65
CAS No.2641451-44-5
Chemical FormulaC8H10BrNO
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 73 (Mixture of E/Z-isomers) structure
73
甲磺酸伊马替尼杂质73 (混合E/Z构型)Imatinib Mesylate Impurity 73 (Mixture of E/Z-isomers)
Imatinib Mesylate Impurity 73 (Mixture of E/Z-isomers)
CAS No.1407124-80-4
Chemical FormulaC32H26N10O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 74 structure
74
甲磺酸伊马替尼杂质74Imatinib Mesylate Impurity 74
Imatinib Mesylate Impurity 74
CAS No.1131605-15-6
Chemical FormulaC9H12N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 82 structure
82
甲磺酸伊马替尼杂质82Imatinib Mesylate Impurity 82
Imatinib Mesylate Impurity 82
CAS No.837-64-9
Chemical FormulaC10H13N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 83 structure
83
甲磺酸伊马替尼杂质83Imatinib Mesylate Impurity 83
Imatinib Mesylate Impurity 83
CAS No.2118894-75-8
Chemical FormulaC16H20N4O
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 84 structure
84
甲磺酸伊马替尼杂质84Imatinib Mesylate Impurity 84
Imatinib Mesylate Impurity 84
CAS No.2940952-21-4
Chemical FormulaC8H10BrNO
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 85 structure
85
甲磺酸伊马替尼杂质85Imatinib Mesylate Impurity 85
Imatinib Mesylate Impurity 85
CAS No.2920443-23-6
Chemical FormulaC8H10BrNO
Purity>95%询价On request
10mg25mg50mg100mg
Imatinib Mesylate Impurity 86 structure
86
甲磺酸伊马替尼杂质86Imatinib Mesylate Impurity 86
Imatinib Mesylate Impurity 86
CAS No.66521-53-7
Chemical FormulaC10H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

甲磺酸伊马替尼 —— 研究文献与合成路线Imatinib Mesylate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 甲磺酸伊马替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Imatinib Mesylate. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms
    Nageswari A, Reddy KV, Mukkanti K · Journal of pharmaceutical and biomedical analysis · 2012 · 被引 17cited 17
  2. Identification of imatinib mesylate degradation products obtained under stress conditions
    Szczepek WJ, Kosmacińska B, Bielejewska A, et al. · Journal of pharmaceutical and biomedical analysis · 2007 · 被引 16cited 16
  3. Reversed-phase liquid chromatography analysis of imatinib mesylate and impurity product in Glivec capsules
    Ivanovic D, Medenica M, Jancic B, et al. · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2004 · 被引 14cited 14
  4. Experimental design in reversed-phase high-performance liquid chromatographic analysis of imatinib mesylate and its impurity
    Medenica M, Jancic B, Ivanovic D, et al. · Journal of chromatography. A · 2004 · 被引 13cited 13
  5. Determination of sulfonate ester genotoxic impurities in imatinib mesylate by gas chromatography with mass spectrometry
    Zhang C, Huang L, Wu Z, et al. · Journal of separation science · 2016 · 被引 7cited 7
  6. Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC-MS/MS and dissolution profile
    Wolff FC, Dillenburg TL, Venzon Antunes M, et al. · Biomedical chromatography : BMC · 2018 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF IMATINIB MESYLATE
    KADABOINA RAJASEKHAR, NARIYAM MUNASWAMY SEKHAR, VINJAMURI RAGHUPATI RAMA SUBRAHMANYAM, KOMATI SHRAVAN KUMAR, et al. · 公开号 WO2012015999WO2012015999 · 2012
  2. PROCESS FOR IMATINIB MESYLATE
    PARTHASARADHI REDDY BANDI, RATHNAKAR REDDY KURA, MURALIDHARA REDDY DASARI, RAJI REDDY RAPOLU, et al. · 公开号 WO2012004801WO2012004801 · 2012
  3. PROCESS FOR THE PREPARATION OF ALPHA FORM OF IMATINIB MESYLATE
    ASHWANI SHARMA, CHANDRABHAN MADHAV HIRE, ROHIT CHATURVEDI, RAJAN GUPTE · 公开号 WO2011099039WO2011099039 · 2011
  4. PREPARATION OF IMATINIB MESYLATE
    KADABOINA RAJASEKHAR, NARIYAM MUNASWAMY SEKHAR, PATEL VIJAY BHAILALBHAI · 公开号 EP2291366EP2291366 · 2011
  5. PREPARATION OF IMATINIB MESYLATE
    KADABOINA RAJASEKHAR, NARIYAM MUNASWAMY SEKHAR, PATEL VIJAY BHAILALBHAI · 公开号 WO2009151899WO2009151899 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

甲磺酸伊马替尼 杂质谱研究要点Imatinib Mesylate — impurity profiling notes

下面这些是拿到 甲磺酸伊马替尼 的 55 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 55 impurity entries for Imatinib Mesylate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances